Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018028491) INDOLEAMINE2,3-DIOXYGENASE INHIBITORS AND USES THEREOF IN PHARMACY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/028491 International Application No.: PCT/CN2017/095669
Publication Date: 15.02.2018 International Filing Date: 02.08.2017
IPC:
C07D 487/04 (2006.01) ,A61K 31/4188 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4188
condensed with heterocyclic ring systems, e.g. biotin, sorbinil
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
苏州国匡医药科技有限公司 SUZHOU GUOKUANG PHARMTECH. CO., LTD. [CN/CN]; 中国江苏省苏州市 工业园区生物纳米园A3-412 No. 218 Xinghu Rd., SIP Biobay Suzhou, Jiangsu 215125, CN
杭州阿诺生物医药科技股份有限公司 ADLAI NORTYE BIOPHARMA CO., LTD. [CN/CN]; 中国浙江省杭州市 经济技术开发区六号大街452号2号楼21楼 21/F, Bld.2, No.452, 6th St., Eco. & Tech. Development Area Hangzhou, Zhejiang 310018, CN
Inventors:
梅德盛 MEI, Desheng; CN
刘爱风 LIU, Aifeng; CN
汪奎 WANG, Kui; CN
孙靖 SUN, Jing; CN
Agent:
上海专利商标事务所有限公司 SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC; 中国上海市 桂平路435号 435 Guiping Road Shanghai 200233, CN
Priority Data:
201610647204.309.08.2016CN
Title (EN) INDOLEAMINE2,3-DIOXYGENASE INHIBITORS AND USES THEREOF IN PHARMACY
(FR) INHIBITEURS INDOAMINE2, 3-DIOXYGÉNASE ET LEURS UTILISATIONS EN PHARMACIE
(ZH) 吲哚胺2,3-双加氧酶抑制剂及其在药学中的用途
Abstract:
(EN) A compound for one or more indoleamine2,3-dioxygenase inhibitors comprising pharmaceutical components of the compound and a preparation; and uses of the indoleamine2,3-dioxygenase inhibitors. The indoleamine2,3-dioxygenase inhibitors can be separately used or used in combination with other drugs, and are used for treating symptoms related to the indoleamine2,3-dioxygenase.
(FR) L'invention concerne en outre un composé pour un ou plusieurs inhibiteurs indoamine2, 3-dioxygénase comprenant des composants pharmaceutiques du composé et une préparation; et des utilisations des inhibiteurs indoamine2, 3-dioxygénase. Les inhibiteurs indoamine2, 3-dioxygénase peuvent être utilisés séparément ou en combinaison avec d'autres médicaments, et sont utilisés pour traiter des symptômes liés à l'indoamine2, 3-dioxygénase.
(ZH) 一种或多种吲哚胺2,3-双加氧酶的抑制剂化合物,包含该化合物的药物组分及制剂,及这类吲哚胺2,3-双加氧酶抑制剂的用途,可单一用药或与其它药物联合用药,用来治疗与吲哚胺2,3-双加氧酶相关的症状。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)